We know facts, rest is just 2nd year arithmetics:
1. Japan sells 12 000 scripts monthly ..in US we should do min 20 000 per month..and Japan is growing 40% YoY...
2. Insurable drug. Confirmed.
3. Price between 600 to 700usd per script.. gives us usd 160mln in Sales
4. Margins are generally very strong 65 - 75% ( Japan sells at usd 70 but still makes $$)
5. 20 to 30 Sales people, cost approx 30mln usd per.a.
6. EBITA will be around 80 to 90mln Usd
7. Product is growing at double digits ( proof Japan) ..so in short period- can have 50% more revenue..
8. Europe easly 25% immediate upside..
BOT - Anything but charting, page-5213
-
- There are more pages in this discussion • 6,459 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $608.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.3¢ | 32.5¢ | $1.200M | 3.588M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 349093 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 25403 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |